Lilly’s Newest Bull Says Near 300% Rally Is Only the Beginning

Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the...

By Angel Adegbesan · Bloomberg Markets

Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the world’s most valuable pharmaceutical company.